Apollomics, Inc. (NASDAQ:APLMW) Sees Significant Drop in Short Interest

Apollomics, Inc. (NASDAQ:APLMW) was the target of a large decrease in short interest in February. As of February 28th, there was short interest totalling 3,500 shares, a decrease of 20.5% from the February 13th total of 4,400 shares. Based on an average daily volume of 29,700 shares, the days-to-cover ratio is currently 0.1 days.

Apollomics Stock Performance

Shares of NASDAQ APLMW opened at $0.01 on Tuesday. Apollomics has a 12 month low of $0.01 and a 12 month high of $0.03. The firm has a fifty day simple moving average of $0.01 and a two-hundred day simple moving average of $0.01.

About Apollomics

Apollomics, Inc, a biotechnology company, engages in the discovery and development of mono and combination oncology therapies to harness the immune system and target specific molecular pathways to inhibit cancer. Its pipeline consists of various development-stage assets, including novel and humanized monoclonal antibodies that restore the body's immune system to recognize and kill cancer cells, and targeted therapies against uncontrolled growth signaling pathways.